BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 10433313)

  • 1. Accelerated fractionated proton/photon irradiation to 90 cobalt gray equivalent for glioblastoma multiforme: results of a phase II prospective trial.
    Fitzek MM; Thornton AF; Rabinov JD; Lev MH; Pardo FS; Munzenrider JE; Okunieff P; Bussière M; Braun I; Hochberg FH; Hedley-Whyte ET; Liebsch NJ; Harsh GR
    J Neurosurg; 1999 Aug; 91(2):251-60. PubMed ID: 10433313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial.
    Fitzek MM; Thornton AF; Harsh G; Rabinov JD; Munzenrider JE; Lev M; Ancukiewicz M; Bussiere M; Hedley-Whyte ET; Hochberg FH; Pardo FS
    Int J Radiat Oncol Biol Phys; 2001 Sep; 51(1):131-7. PubMed ID: 11516862
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advanced prostate cancer: the results of a randomized comparative trial of high dose irradiation boosting with conformal protons compared with conventional dose irradiation using photons alone.
    Shipley WU; Verhey LJ; Munzenrider JE; Suit HD; Urie MM; McManus PL; Young RH; Shipley JW; Zietman AL; Biggs PJ
    Int J Radiat Oncol Biol Phys; 1995 Apr; 32(1):3-12. PubMed ID: 7721636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I/II trial of hyperfractionated concomitant boost proton radiotherapy for supratentorial glioblastoma multiforme.
    Mizumoto M; Tsuboi K; Igaki H; Yamamoto T; Takano S; Oshiro Y; Hayashi Y; Hashii H; Kanemoto A; Nakayama H; Sugahara S; Sakurai H; Matsumura A; Tokuuye K
    Int J Radiat Oncol Biol Phys; 2010 May; 77(1):98-105. PubMed ID: 19695794
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimizing cancer radiotherapy with 2-deoxy-d-glucose dose escalation studies in patients with glioblastoma multiforme.
    Singh D; Banerji AK; Dwarakanath BS; Tripathi RP; Gupta JP; Mathew TL; Ravindranath T; Jain V
    Strahlenther Onkol; 2005 Aug; 181(8):507-14. PubMed ID: 16044218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cauda equina tolerance to high-dose fractionated irradiation.
    Pieters RS; Niemierko A; Fullerton BC; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):251-7. PubMed ID: 15993548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of patients with primary glioblastoma multiforme with standard postoperative radiotherapy and radiosurgical boost: prognostic factors and long-term outcome.
    Shrieve DC; Alexander E; Black PM; Wen PY; Fine HA; Kooy HM; Loeffler JS
    J Neurosurg; 1999 Jan; 90(1):72-7. PubMed ID: 10413158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypofractionated intensity-modulated radiotherapy for primary glioblastoma multiforme.
    Floyd NS; Woo SY; Teh BS; Prado C; Mai WY; Trask T; Gildenberg PL; Holoye P; Augspurger ME; Carpenter LS; Lu HH; Chiu JK; Grant WH; Butler EB
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):721-6. PubMed ID: 14967426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and efficacy of permanent iodine-125 seed implants and carmustine wafers in patients with recurrent glioblastoma multiforme.
    Darakchiev BJ; Albright RE; Breneman JC; Warnick RE
    J Neurosurg; 2008 Feb; 108(2):236-42. PubMed ID: 18240917
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Locally challenging osteo- and chondrogenic tumors of the axial skeleton: results of combined proton and photon radiation therapy using three-dimensional treatment planning.
    Hug EB; Fitzek MM; Liebsch NJ; Munzenrider JE
    Int J Radiat Oncol Biol Phys; 1995 Feb; 31(3):467-76. PubMed ID: 7852108
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of recurrent glioblastoma multiforme with GliaSite brachytherapy.
    Chan TA; Weingart JD; Parisi M; Hughes MA; Olivi A; Borzillary S; Alahakone D; Detorie NA; Wharam MD; Kleinberg L
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1133-9. PubMed ID: 15990019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyperfractionated and accelerated-hyperfractionated radiotherapy for glioblastoma multiforme.
    Nieder C; Nestle U; Ketter R; Kolles H; Gentner SJ; Steudel WI; Schnabel K
    Radiat Oncol Investig; 1999; 7(1):36-41. PubMed ID: 10030622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serial proton magnetic resonance spectroscopy imaging of glioblastoma multiforme after brachytherapy.
    Wald LL; Nelson SJ; Day MR; Noworolski SE; Henry RG; Huhn SL; Chang S; Prados MD; Sneed PK; Larson DA; Wara WM; McDermott M; Dillon WP; Gutin PH; Vigneron DB
    J Neurosurg; 1997 Oct; 87(4):525-34. PubMed ID: 9322843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment outcomes for patients with glioblastoma multiforme and a low Karnofsky Performance Scale score on presentation to a tertiary care institution. Clinical article.
    Marina O; Suh JH; Reddy CA; Barnett GH; Vogelbaum MA; Peereboom DM; Stevens GH; Elinzano H; Chao ST
    J Neurosurg; 2011 Aug; 115(2):220-9. PubMed ID: 21548745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Volumetric analysis of 18F-FDG PET in glioblastoma multiforme: prognostic information and possible role in definition of target volumes in radiation dose escalation.
    Tralins KS; Douglas JG; Stelzer KJ; Mankoff DA; Silbergeld DL; Rostomily RC; Hummel S; Scharnhorst J; Krohn KA; Spence AM
    J Nucl Med; 2002 Dec; 43(12):1667-73. PubMed ID: 12468518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The use of hypofractionated intensity-modulated irradiation in the treatment of glioblastoma multiforme: preliminary results of a prospective trial.
    Sultanem K; Patrocinio H; Lambert C; Corns R; Leblanc R; Parker W; Shenouda G; Souhami L
    Int J Radiat Oncol Biol Phys; 2004 Jan; 58(1):247-52. PubMed ID: 14697445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy for chordoma and chondrosarcoma of the skull base and the cervical spine. Prognostic factors and patterns of failure.
    Noël G; Habrand JL; Jauffret E; de Crevoisier R; Dederke S; Mammar H; Haie-Méder C; Pontvert D; Hasboun D; Ferrand R; Boisserie G; Beaudré A; Gaboriaud G; Guedea F; Petriz L; Mazeron JJ
    Strahlenther Onkol; 2003 Apr; 179(4):241-8. PubMed ID: 12707713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and validation of a prognostic score to predict outcome after re-irradiation of recurrent glioma.
    Combs SE; Edler L; Rausch R; Welzel T; Wick W; Debus J
    Acta Oncol; 2013 Jan; 52(1):147-52. PubMed ID: 22686472
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Postoperative hypofractionated radiotherapy in glioblastoma multiforme.
    Arslan M; Karadeniz AN; Aksu G; Güveli M; Fayda M; Doğan AK; Akyüz F
    J BUON; 2006; 11(1):39-42. PubMed ID: 17318950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.